Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2398 | 2189 | 37.9 | 83% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1728 | 6064 | ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//SUMO |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ACUTE PROMYELOCYTIC LEUKEMIA | Author keyword | 476 | 59% | 25% | 541 |
2 | PML RAR ALPHA | Author keyword | 109 | 71% | 4% | 89 |
3 | APL | Author keyword | 87 | 46% | 6% | 142 |
4 | ALL TRANS RETINOIC ACID | Author keyword | 80 | 24% | 13% | 285 |
5 | ACUTE PROMYELOCYTIC LEUKAEMIA | Author keyword | 77 | 59% | 4% | 87 |
6 | RETINOIC ACID SYNDROME | Author keyword | 38 | 69% | 2% | 33 |
7 | ATRA | Author keyword | 32 | 28% | 5% | 100 |
8 | PML RARA | Author keyword | 26 | 63% | 1% | 26 |
9 | PROMYELOCYTIC | Author keyword | 22 | 68% | 1% | 19 |
10 | T1517 | Author keyword | 19 | 63% | 1% | 19 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACUTE PROMYELOCYTIC LEUKEMIA | 476 | 59% | 25% | 541 | Search ACUTE+PROMYELOCYTIC+LEUKEMIA | Search ACUTE+PROMYELOCYTIC+LEUKEMIA |
2 | PML RAR ALPHA | 109 | 71% | 4% | 89 | Search PML+RAR+ALPHA | Search PML+RAR+ALPHA |
3 | APL | 87 | 46% | 6% | 142 | Search APL | Search APL |
4 | ALL TRANS RETINOIC ACID | 80 | 24% | 13% | 285 | Search ALL+TRANS+RETINOIC+ACID | Search ALL+TRANS+RETINOIC+ACID |
5 | ACUTE PROMYELOCYTIC LEUKAEMIA | 77 | 59% | 4% | 87 | Search ACUTE+PROMYELOCYTIC+LEUKAEMIA | Search ACUTE+PROMYELOCYTIC+LEUKAEMIA |
6 | RETINOIC ACID SYNDROME | 38 | 69% | 2% | 33 | Search RETINOIC+ACID+SYNDROME | Search RETINOIC+ACID+SYNDROME |
7 | ATRA | 32 | 28% | 5% | 100 | Search ATRA | Search ATRA |
8 | PML RARA | 26 | 63% | 1% | 26 | Search PML+RARA | Search PML+RARA |
9 | PROMYELOCYTIC | 22 | 68% | 1% | 19 | Search PROMYELOCYTIC | Search PROMYELOCYTIC |
10 | T1517 | 19 | 63% | 1% | 19 | Search T1517 | Search T1517 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PML RAR ALPHA | 210 | 52% | 13% | 286 |
2 | T15 17 TRANSLOCATION | 169 | 63% | 8% | 172 |
3 | DIFFERENTIATION THERAPY | 169 | 53% | 10% | 226 |
4 | TRANS RETINOIC ACID | 163 | 21% | 31% | 678 |
5 | RAR ALPHA | 95 | 29% | 13% | 278 |
6 | ANTHRACYCLINE MONOCHEMOTHERAPY | 93 | 88% | 2% | 44 |
7 | TRANSRETINOIC ACID | 91 | 79% | 3% | 59 |
8 | T15 17 | 87 | 57% | 5% | 104 |
9 | PETHEMA | 75 | 83% | 2% | 43 |
10 | ALPHA FUSION GENE | 72 | 78% | 2% | 47 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Acute promyelocytic leukemia: from highly fatal to highly curable | 2008 | 394 | 81 | 75% |
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet | 2009 | 254 | 115 | 74% |
Modern Approaches to Treating Acute Promyelocytic Leukemia | 2011 | 69 | 60 | 85% |
ALL-TRANS-RETINOIC ACID AS A DIFFERENTIATING AGENT IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA | 1995 | 310 | 75 | 96% |
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure | 2010 | 124 | 143 | 64% |
Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia | 2012 | 35 | 80 | 75% |
Acute promyelocytic leukemia: What is the new standard of care? | 2014 | 5 | 73 | 86% |
How to manage acute promyelocytic leukemia | 2012 | 29 | 98 | 79% |
Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia | 2013 | 22 | 99 | 65% |
ACUTE PROMYELOCYTIC LEUKEMIA | 1993 | 683 | 123 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SHANGHAI HEMATOL | 9 | 17% | 2.2% | 49 |
2 | UMR 7212 | 7 | 57% | 0.4% | 8 |
3 | CNRSUPR 9051 | 6 | 100% | 0.2% | 4 |
4 | INSERM U496 | 5 | 63% | 0.2% | 5 |
5 | BIOL CELLULAIRE HEMATOPOIET | 4 | 36% | 0.4% | 9 |
6 | U496 | 3 | 35% | 0.4% | 8 |
7 | MED UNIV KLIN MANNHEIM 3 | 3 | 57% | 0.2% | 4 |
8 | UMR 944 | 3 | 57% | 0.2% | 4 |
9 | G HAYEM | 3 | 32% | 0.4% | 8 |
10 | NEUROONCOHEMATOL | 3 | 38% | 0.3% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000204221 | DAXX//PML//PML NUCLEAR BODIES |
2 | 0.0000192556 | ARSENIC TRIOXIDE//AS2O3//ARSENIC TRIOXIDE AS2O3 |
3 | 0.0000087492 | RETINOYLATION//RETINOBENZOIC ACID//RXR |
4 | 0.0000081021 | LEUKEMIA CELL DIFFERENTIATION//DUNN OSTEOSARCOMA CELLS//LOW DOSE CYTOSINE ARABINOSIDE |
5 | 0.0000075680 | LEUKOSTASIS//HYPERLEUKOCYTOSIS//LEUCOSTASIS |
6 | 0.0000071464 | FENRETINIDE//4 HPR//N 4 HYDROXYPHENYL RETINAMIDE |
7 | 0.0000069165 | TETRASOMY 8//NEAR TETRAPLOIDY//TRISOMY 4 |
8 | 0.0000065479 | ACUTE MYELOID LEUKEMIA//GEMTUZUMAB OZOGAMICIN//AML |
9 | 0.0000053908 | FLT3//FLT3 ITD//NPM1 |
10 | 0.0000049226 | POKEMON//BCL6//HIC1 |